In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...